Prelude Capital Management’s Athenahealth, Inc. ATHN Stock Holding History

Prelude Capital Management’s Portfolio ATHN Stock Details ATHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-2,000	Closed	-$264K	–	2400
2018 Q4	$264K	Buy	+2,000	New	+$256K	0.02%	643
2015 Q1	–	Sell	-4,000	Closed	-$583K	–	2324
2014 Q4	$583K	Sell	4,000 -1,000	-20%	-$126K	0.09%	268
2014 Q3	$658K	Sell	5,000 -1,500	-23%	-$198K	0.09%	271
2014 Q2	$813K	Buy	6,500 +2,500	+63%	+$323K	0.11%	226
2014 Q1	$641K	Hold	4,000	–	–	0.09%	312
2013 Q4	$538K	Hold	4,000	–	–	0.09%	326
2013 Q3	$434K	Buy	+4,000	New	+$432K	0.07%	332

Prelude Capital Management's ATHN Position: Q1 2019 in Review

Prelude Capital Management sold out of Athenahealth, Inc. (ATHN) in Q1 2019, closing a stake of 129,949 shares — an estimated $17.1M sold.

Prelude Capital Management first reported a position in ATHN in Q2 2013 and held it in 9 quarters. The position peaked at $17.1M in Q4 2018. 0 funds tracked by Wall St. Rank hold ATHN as of Q1 2019.

Prelude Capital Management reported no remaining Athenahealth, Inc. position as of Q1 2019 after selling out during the quarter.
Prelude Capital Management sold 129,949 Athenahealth, Inc. shares in Q1 2019, an estimated $17.1M.
Prelude Capital Management first reported a position in Athenahealth, Inc. in Q2 2013 and held it in 9 quarters.
Prelude Capital Management's Athenahealth, Inc. position peaked at $17.1M in Q4 2018.
0 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q1 2019.

Based on Prelude Capital Management's 13F filing for Q1 2019, filed 15 May 2019.